A pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment

A pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment - clomiphene and thin endometrium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007288

Enrollment

Registered

2012-02-15

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A prospective Randomized Controlled Trial.

Interventions

patients who received a standard clomiphene citrate treatment on days 5-9 (control group) patients who were given 25 mg/day clomiphene citrate on days 5-9 (half-dose group) patients who were given 50

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients who were diagnosed as having a thin endometrium (< 8 mm) during the standard clomiphene citrate treatment cycle were recruited in this study.

Exclusion criteria

Exclusion criteria: patients were excluded if they had myoma, adenomyosis, congenital uterine anomaly, or ovarian tumors. Patients were also excluded if they used estrogens, progesterone, androgens, or had chronic use of any medication, including nonsteroidal anti-inflammatory agents.

Design outcomes

Primary

Measure	Time frame
Endometrial thickness at the induction of ovulation was assessed by ultrasonography.	—

Countries

Japan

Contacts

Public ContactHiroshi Tamura

Yamaguchi University Graduate School of Medicine Department of Obstetrics and Gynecology

hitamura@yamaguchi-u.ac.jp+81-836-22-2288

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026